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Objectives. We evaluated our immediate and midterm (mean
4.3 years) results of balloon dilation of critical valvular aortic
stenosis in 33 neonates.
Background. Balloon dilation has been used as an alternative to
surgical treatment. Reports to date consist of small series (largest
16 babies) with short-term follow-up (longest 4.8 years).
Methods. From 1985 to 1991, 33 neonates had dilation at a
mean age of 13 days and a mean weight of 3.4 kg. Nineteen of the
neonates (58%) were intubated and received prostaglandins, and
94% had other cardiac abnormalities.
Results. The dilation was completed retrograde in 31 of the
neonates (umbilical artery in 11 and femoral artery in 20) and
anterograde (femoral vein) in 2. The average immediate peak
gradient and left ventricular end-diastolic pressure reductions
were 54% and 20%, respectively. The overall mortality rate was
12% (three early deaths and one late). All 20 neonates dilated
through a femoral artery initially had pulse loss with restoration
in 35% after thrombolytic therapy. At 8.3 years, survival and
freedom of reintervention probability rates were 88% and 64%,
respectively. At mean 4.3 years of follow-up, 83% of the survivors
were asymptomatic; Doppler study revealed a maximal instanta-
neous gradient <50 mm Hg in 65% of neonates and significant
aortic regurgitation in 14%.
Conclusions. This study confirms that dilation of aortic stenosis
in neonates is effective; reintervention (mostly redilation) is
frequent (40%); and midterm survival is encouraging (88%).
(J Am Coll Cardiol 1997;29:442–7)
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Transvascular balloon dilation for critical aortic stenosis in
neonates, initially reported in 1986 (1), has been shown as
efficacious as surgical treatment in terms of gradient relief and
appearance of aortic regurgitation (2–15). However, the larg-
est study reported to date consists of 16 neonates (6) and the
longest follow-up period is 4.8 years (15). This study was
undertaken to review our experience in 33 neonates with a
mid-term follow-up to 8.3 years (average 4.3) and to compare
our results with other series so treated (2–15) and with those
managed surgically (2,14–29) and by valvotomy, dilators or
balloons.
Methods
Between August 1985 and October 1991, 46 neonates #33
days of age and deemed to be possible two-ventricle survivors
underwent balloon dilation for critical valvular aortic stenosis,
including one neonate who had an arterial switch operation
with severe stenosis of the neoaortic valve. Excluded were
babies with aortic or mitral atresia, or both, and clearly
diminutive left ventricles who were referred for a stage I
Norwood procedure. The echocardiographic anatomic risk
factor score for two-ventricle repair by Rhodes et al. (30) was
retrospectively applied to all patients. Because that study
revealed that infants with echocardiographic scores.2 treated
with balloon valvuloplasty have extremely poor outcomes, 13
neonates with such features (most included in that report)
were excluded, except for brief comparison purposes, leaving
33 neonates as the basis of this report. All available records
were reviewed, including electrocardiograms (ECGs), chest
X-ray films, two-dimensional and Doppler echocardiograms,
cardiac catheterization data and autopsy reports. Cineangio-
cardiograms were reviewed by three observers (E.E., P.M.,
J.O.S.) to evaluate aortic regurgitation and mitral regurgitation
(graded as absent, mild, moderate or severe). In addition, the
aortic valve annulus diameter was measured from the lateral
cineangiogram using catheter size to correct for magnification,
and valve consistency was graded as thin when leaflets mea-
sured ,2 mm, or thick ($2 mm) on either anteroposterior or
lateral cineangiograms.
Dilation was performed using techniques previously de-
scribed in detail (2,8,31). Early death and early reintervention
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were defined as occurring within 30 days of the initial dilation.
Follow-up information was obtained from charts, the referring
cardiologist and parents by a mailed questionnaire. These data
included current symptoms (fainting, dizziness, chest pain,
palpitation, tachpnea, exercise limitation), medications, addi-
tional cardiac interventions, cardiac murmur intensity, pres-
ence of femoral pulses, left ventricular hypertrophy on ECG,
heart size on chest X-ray film, presence and severity of aortic
and mitral regurgitation on echocardiography and maximal
instantaneous and mean Doppler gradients. When available,
repeat catheterization data, including aortic peak to peak
systolic ejection gradient, left ventricular end-diastolic pres-
sure and degree of aortic and mitral regurgitation, were
recorded. Collection of all follow-up information was com-
pleted in 1994. Written informed consent was obtained in
accordance with the guidelines of the Committee on Clinical
Investigation.
Statistical analysis. Data are expressed as mean value 6
SD. Predilation and postdilation comparisons of data were
performed using the paired t test. A p value ,0.05 was
considered significant. An overall survival curve was con-
structed using the Kaplan-Meier method with the end point
being death. Subjects who did not die were censored at the
time of the last follow-up visit.
Results
Predilation observations (33 neonates). The 33 neonates
ranged in age from 1 to 33 days (13 6 12) and in weight from
1.9 to 5.5 kg (3.4 6 0.8). Twenty-six were boys, and at the time
of catheterization 19 were intubated.
On the ECG, left ventricular hypertrophy was present in
55% of the neonates, a strain pattern in 40%, and 15% had
both. On chest X-ray film, cardiomegaly was present in 87%.
Frequently associated cardiac abnormalities as shown by echo-
cardiography or catheterization, or both, included left ventric-
ular dysfunction (82%), atrial septal defect/patent foramen
ovale (82%), mitral regurgitation (67%) and patent ductus
arteriosus (45%) (Table 1).
Immediate results (Table 2). Dilation was completed in
retrograde fashion in 31 neonates (94%)—from the umbilical
artery in 11 (33%) and the femoral artery in 20 (61%)—and in
anterograde fashion in 2 (6%) through a femoral vein. The
average gradient reduction was 54% and left ventricular
end-diastolic decrease 20%, and the incidence of technical
success (defined as gradient reduction .50% with no signifi-
cant aortic regurgitation) was 73%. There was no correlation
between valve thickness and either catheterization peak gradi-
ent reduction or aortic regurgitation. The average final balloon/
aortic annulus ratio was 0.8.
Procedure complications (Table 3). There were three
procedure-related deaths. Of these, one was due to sepsis after
a prolonged attempt at dilation through the umbilical artery,
and another to severe aortic regurgitation resulting from wire
perforation and subsequent cusp dilation. Both were very early
in this series. The other died of wire perforation of the left
ventricle, causing tamponade. Other major complications in-
cluded cardiac arrest in four (all resuscitated) babies, left
anterior descending coronary artery occlusion in one and
aortic arch flaps later found on echocardiography in two. All 20
neonates dilated through a femoral artery initially had pulse
loss, but after thrombolytic therapy the pulse returned in 35%
of them.
Overall mortality and survival. The overall mortality rate
was 12% (4 of 33 neonates)—with 3 (9%) early and 1 (3%) late
(12 months) death. All three early deaths were related to
Table 1. Associated Cardiac Abnormalities at Hospital Admission in
33 Neonates
Abnormalities No. (%)
LV dysfunction 27 (82)
Mitral regurgitation 22 (67)
PDA 15 (45)
ASD/PFO 27 (82)
Mitral stenosis 1 (3)
Multiple VSD 1 (3)
PAPVC 1 (3)
DTGA, VSD, PS, after ASO 1 (3)
ASD/PFO 5 atrial septal defect/patent foramen ovale; ASO 5 arterial
switch operation; DTGA 5 dextro transposition of great arteries; LV 5 left
ventricle; PAPVC 5 partial anomalous pulmonary venous connection; PDA 5
patent ductus arteriosus; PS 5 pulmonary stenosis; VSD 5 ventricular septal
defect.
Table 2. Immediate Results in 33 Neonates
Variable
PSEG
Pre 59 6 24
Post 27 6 18
p value ,0.001
LVEDP
Pre 20 6 8
Post 16 6 6
p value 0.024
BAR 0.8 6 0.1
Technical success 24/33 (73%)
Data presented are mean value 6 SD or number (%) of patients. BAR 5
final balloon/aortic annulus ratio; LVEDP 5 left ventricular end-diastolic
pressure (mm Hg); Pre and Post 5 before and after dilation, respectively;
PSEG 5 peak to peak systolic ejection gradient (mm Hg).
Table 3. Procedure Complications in 33 Neonates
Mortality—3 (9%)
Wire perforation of LV with tamponade—1
Cusp perforation by wire, then BD, then severe AR—1
Sepsis associated with prolonged umbilical artery approach—1
Cardiac arrest—4 (12%)
Sepsis—3 (9%)
AR (moderate to severe)—2 (6%)
LAD occlusion—1 (3%)
AR 5 aortic regurgitation; BD 5 balloon dilation; LAD 5 left anterior
descending coronary artery; LV 5 left ventricle.
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dilation complications, and the late death (overseas) occurred
in the baby whose neoaortic valve was dilated after an aterial
switch operation. In this last patient with moderate aortic
regurgitation at most following the dilation, we were unable to
obtain any other follow-up details. The predicted survival rate
was 88% up to 8.3 years of follow-up, in contrast to only 8% at
24 months in those with an echocardiographic score $2 (Fig.
1).
Reintervention. A second procedure was performed in 12
patients (40%). This second procedure (mostly redilation) was
undertaken by 1 month in 12%, by 4 months in 31% and by 96
months in 36% of the neonates. A third redilation procedure
was performed in two patients, one of whom later underwent
a surgical valvotomy followed by heart transplantation.
Midterm results. Of the 33 neonates, 29 (88%) were alive
at completion of the study, and follow-up data were obtained
in all at 4.3 6 1.8 years (range 2.2 to 8.3) after dilation (Table
4). Clinically, 83% of them were asymptomatic. No episodes of
bacterial endocarditis or serious arrhythmia were noted. Mur-
murs of aortic stenosis (#4/6) were present in all neonates, and
aortic regurgitation in 24%. The femoral pulse was absent in
nine babies, but without any obvious leg length discrepancy. At
the most recent Doppler study, the instantaneous gradient was
53 6 19 mm Hg (range 15 to 98), and aortic regurgitation was
graded as moderate to severe in four (14%). At cardiac
catheterization in 19 neonates, performed in the majority
because of suspected significant residual obstruction, at 2.4 6
2 years (range 0.1 to 6.6) after dilation, the gradient was 53 6
31 mm Hg (range 9 to 95), left ventricular end-diastolic
pressure 19 6 9 mm Hg (range 10 to 40) and cardiac output
(measured in 13) 4.1 6 1.0 liter/min per m2 (range 2.1 to 6.6).
Aortic regurgitation, moderate to severe, was present in 11%.
An occluded external iliac–common femoral artery was iden-
tified in four patients with adequate collateral flow as shown by
angiography.
Additional defects were encountered in 10 patients, con-
sisting of mitral stenosis in four, membranous subvalvular
aortic stenosis in three, coarctation of the aorta in two,
double-chambered right ventricle in one and partial anoma-
lous pulmonary venous return in another. On review of the
initial echocardiographic and catheterization data, all but the
last and one stenotic mitral valve appeared to have developed
during follow-up. In contrast, some abnormalities present
before dilation had spontaneously resolved or improved during
follow-up. Decreased left ventricular function, initally present
in 23 (79%) of 29 neonates (severe in 13), improved in all,
being normal in 87%. Mitral regurgitation, noted in 18 patients
(62%; moderate in 6), improved in 13 (72%), being absent in
9 (50%) and mild at most in the other 9. A small atrial defect,
with or without left to right shunting and noted initially in 23,
had spontaneously closed in 21 neonates (91%). No patient
had a patent ductus arteriosus at follow-up, all 11 having closed
spontaneously.
Discussion
Critical aortic stenosis in neonates is a rare lesion; among
infants it accounts for 2% of life-threatening heart disease
(32). Although it may be tolerated in fetal life when increased
flow through the right heart can compensate for reduced flow
across the aortic valve, after closure of the patent ductus
arteriosus after delivery, left ventricular failure with its se-
quelae rapidly develops. Initially surgical valvotomy was the
sole hope of survival in these neonates, but in recent years
management by transvascular balloon dilation has been intro-
duced as an alternative (1–15).
Survival (Table 5). In surgical series reviewed (2,14–29)
from 1974 to 1995, among 212 cases reported, there were 136
Figure 1. Kaplan-Meier survival curve for neonates after balloon
dilation as initial treatment for critical aortic stenosis. HLHS(v) 5
hypoplastic left heart syndrome (variant group, echocardiographic
score $2 [30]).
Table 4. Follow-Up Data
Variable No. (%)
Clinical
Symptoms 5 (17)
On medication 11 (38)
Murmur
Systolic 29 (100)
Diastolic 7 (24)
ECG
LVH 15 (52)
Strain pattern 3 (10)
Chest X-ray film: cardiomegaly 10(35)
Echocardiography
MIG .50 mm Hg 10 (35)
Moderate to severe AR 4 (14)
Catheterization*
PSEG .50 mm Hg 5 (26)
Moderate to severe AR 2 (11)
*Available in 19 patients only. AR 5 aortic regurgitation; ECG 5 electro-
cardiography; LVH 5 left ventricular hypertrophy; MIG 5 maximal instanta-
neous gradient; PSEG 5 peak systolic ejection gradient.
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(64%) early and 123 (58%) late survivors at a mean 2.5 years
of follow-up. In many of these series, neonates with hypoplastic
left heart features were included. If we include 13 such infants
initially managed by balloon dilation during the same period,
then of our total 46 neonates, early and late survival rates are
76% and 63%, respectively. In some of the surgical series
(15–18,20,23), neonates with hypoplastic left heart syndrome
features were excluded: in the valvotomy series of Turley et al.
(23), early and late survival rates were 87.5% and 52.5%,
respectively, and in the series of Mosca et al. (15), in which
Hegar dilators were used, the rates were 90.5% and 86%,
respectively. In percutaneous and umbilical balloon dilation
series (2–7,9–11,13–15), among 85 neonates (1986 to 1995),
there were 59 (69%) early and 53 (63%) late survivors at a
mean 1.1 year of follow-up. Some authors (3,10,11) excluded
neonates with hypoplastic left heart syndrome features. If we
include our 13 neonates with an echocardiographic score $2,
then in our total of 46 neonates, there were 35 (76%) early and
29 (63%) late survivors at a mean 4.3 years of follow-up.
Although our results in those with hypoplastic left heart
syndrome features (echocardiographic score $2) were very
poor (39% early, 8% late survival), in those with an echocar-
diographic score ,2 the survival rates were most encourag-
ing—91% early and 88% late survival rates with the longest
follow-up reported to date. Thus, our results suggest that
transvascular balloon dilation is comparable to the more recent
surgical results as the initial method of management of these
babies without hypoplastic left heart syndrome features.
Reintervention (Table 5). Among surgically managed neo-
nates, the incidence of a second cardiac procedure, most
commonly a repeat surgical valvotomy, ranged from 0% to
50% (mean 17%), undertaken at a mean 2.5 years of follow-up.
Among the balloon dilation-managed neonates from other
institutions, a second procedure was undertaken in 24% during
a mean follow-up of 1.1 year. Repeat dilation, surgical val-
votomy and Norwood stage I operation were the most common
reintervention procedures. In the current series, a second
procedure was carried out in 40% during a mean follow-up
period of 4.3 years, most commonly a repeat dilation. It is
likely that the higher incidence of reintervention in our study
group is related to our propensity to repeat dilation at lower
gradient levels (.50 mmHg) and to our longer follow-up time.
At our own institution, among 148 older patients who under-
went dilation during the same era as the current series, 25%
underwent reintervention within 4 years of follow-up, a lower
incidence than that in our neonatal patients (33).
Associated lesions. It has been suggested that isolated
critical aortic stenosis in the neonatal period represents the
favorable end of the hypoplastic left heart syndrome spectrum,
whereas those patients with atresia of one or more structures
are the most severely affected (34–36). Between these two
extremes are babies with aortic stenosis with less severe
hypoplasia of one or more left heart structures in whom
survival with two ventricles and a valvotomy alone is question-
able. Balloon dilation in such neonates, identified using the
scoring system as described by Rhodes et al. (30), has been
shown to be ineffective. Indeed, when we attempted a Nor-
wood procedure after dilation in the ensuing weeks, some now
with aortic regurgitation, survival was only 16%. Thus, at
present we use this scoring system to guide managment, and
since this series of 30 neonates with both aortic and mitral
stenosis, there have been 12 survivors (30%) after a Norwood
operation as the first procedure. In the present series of 33
neonates, all with a score ,2, the early survival rate was 91%
with dilation, and among these clearly there were some lesions
that improved after dilation alone. Atrial defects closed spon-
taneously in 91% of these babies, and mitral regurgitation was
noted in 62%, decreased in 72% and resolved completely in
50%. Dysfunction of the left ventricle improved in all the
neonates, becoming normal in 87%, as has been reported by
other investigators (15). In these survivors, other lesions
previously not evident and necessitating treatment appeared
during follow-up, such as mitral and subaortic stenosis, coarc-
tation of the aorta and double-chambered right ventricle.
Balloon dilation-related complications. There were three
deaths (9%) related to the procedure—namely, sepsis due to a
prolonged attempt to dilate through the umbilical artery (8),
cusp perforation by wire with subsequent cusp dilation (8) and
tamponade due to wire perforation of the left ventricle. These
occurred early in the series and all are considered avoidable.
These complications have also been described by other inves-
tigators (4,10,14,28). Aortic regurgitation, at least moderate in
Table 5. Surgical and Transvascular (percutaneous, umbilical) Balloon Dilation Management of Neonatal
Critical Aortic Stenosis
No. of Cases
(range)
Survival Rate
Reintervention
Rate (range)
Mean Follow-Up
Period (yr) (range)Early Late
Surgical 212 64% 58% 17% 2.5
1974–1994* (7–40) (0–91%) (50–100%) (0–50%) (0.4–4.7)
BD in other studies 85 69% 63% 24% 1.1
1986–1995† (2–16) (46–100%) (50–100%) (0–60%) (0.3–3.1)
BD in this study 33 91% 88% 36% 4.3
(HLHS group included) (46) (76%) (63%) (41%)
*Includes valvotomy, dilators and balloon management; see references 2, 14–23 and 27–29. †See references 1, 3–7,
9–11, 14 and 15. BD 5 balloon dilation; HLHS 5 hypoplastic left heart syndrome with an echocardiographic score of 2.
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degree, was present initially in 6% of neonates (and 11% at
follow-up catheterization), a complication also described in
other dilation series (10,11,14,15) and in surgical reports
(15,16,20,21,23,28,29). Although unpredictable, we believe it
prudent to initially use a balloon that is 90%, at most, the
annular size. We have encountered two instances of aortic arch
flaps visible echocardiographically among survivors, without
hemodynamic sequelae, which may be related to the use of an
0.018-in. (0.045-cm) torque wire with a stiff mandril, along with
a balloon with a larger internal diameter lumen. Preshaping
this wire to the aortic curves, along with a matched balloon
lumen, should eliminate this problem. Femoral pulse loss
occurred initially in all our neonates who underwent dilation
through a femoral artery, with resolution occurring in 35%
after thrombolytic therapy. Although pulses were palpable in
71% of babies at follow-up, patency was uncertain (37,38). Use
of the umbilical artery (8) in 33% in this series and also
advocated by others (4,15), or anterogradely from a vein
(technically the most difficult), eliminates this problem, as
would the novel subscapular artery cut-down approach re-
cently described (39) or the carotid artery approach with which
we have no experience (3).
Follow-up (Table 4). At a mean follow-up of 4.3 years
(range 2.2 to 8.3), 83% of the survivors were asymptomatic,
65% had an instantaneous gradient ,50 mm Hg echocardio-
graphically, 86% had mild aortic regurgitation and 64% were
free from reintervention. Although this follow-up is the longest
to date, these results are similar to those in the more recent
dilation and surgical reports (14,15,23).
Study limitations. This is a retrospective review, and some
of these patients have been included in previous reports
(2,8,30,31). Small variations in measurement of variables used
in the echocardiographic scoring system (30) can influence the
resultant score, and although a score $2 retrospectively pre-
dicted 100% nonsurvival for a two-ventricle repair, further
refinements of this approach are clearly necessary.
Conclusions. This study confirms that transvascular bal-
loon dilation of critical aortic stenosis 1) results in survival
rates better than those in most surgical series of neonates with
adequate-sized left heart structures, and 2) is ineffective in
those with hypoplastic left heart syndrome features. This
procedure continues to be our treatment of choice for this
lesion. Although femoral artery pulse loss was frequent, since
completion of this study in 1991, catheter technology has
continued to advance. For example, balloon catheters up to
6 mm in diameter on a shaft size under 4F with an 0.018-in.
lumen are now available (Medi-Tech, Boston Scientific Cor-
poration). We believe such equipment improvements, along
with more frequent use of the umbilical artery and anterograde
venous approaches, have resulted in less pulse loss.
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